The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3

Phytomedicine. 2009 Mar;16(2-3):146-55. doi: 10.1016/j.phymed.2008.07.013. Epub 2008 Sep 24.

Abstract

The aim of this study was to investigate the antiviral effects of salidroside, a major component of Rhodiola rosea L. First, the antiviral effects of salidroside against coxsackievirus B3 (CVB3) were determined in vitro and in vivo. Then, the effect of salidroside on the mRNA expression of some important cytokines was measured in hearts of infected BALB/c mice by RT-PCR. Salidroside exhibited obvious antiviral effects both in in vitro and in vivo experiments. Salidroside was found to modulate the mRNA expression of interferon-gamma (IFN-gamma), interleukin-10 (IL-10), tumor necrosis factor-alpha (TNF-alpha), and interleukin-2 (IL-2). In conclusion, salidroside possesses antiviral activities against CVB3 and it may represent a potential therapeutic agent for viral myocarditis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Coxsackievirus Infections / drug therapy*
  • Cytokines / genetics
  • Cytokines / metabolism*
  • Enterovirus B, Human / drug effects*
  • Enzymes / blood
  • Glucosides / pharmacology*
  • Glucosides / therapeutic use
  • Heart / virology
  • Male
  • Malondialdehyde / blood
  • Mice
  • Mice, Inbred C57BL
  • Myocardium / pathology
  • Phenols / pharmacology*
  • Phenols / therapeutic use
  • Phytotherapy
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Rhodiola*
  • Superoxide Dismutase / metabolism

Substances

  • Antiviral Agents
  • Cytokines
  • Enzymes
  • Glucosides
  • Phenols
  • RNA, Messenger
  • Malondialdehyde
  • Superoxide Dismutase
  • rhodioloside